LaSara prints a per-day figure beside every price, which is what makes it possible to notice that one of its two peptide products divides by sixty days while its own shop label calls it a monthly subscription.
What LaSara Medical Group charges
Sermorelin: $199/mo — the subscription tier, printed as "Subscribe & Save 20% — $249 $199 — $6.63 per day" beside a "One-Time Purchase — $249 — $8.30 per day". Both divisions resolve to thirty days ($199 ÷ $6.63 = 30.0; $249 ÷ $8.30 = 30.0), and the shop label reads "$199 - Monthly Subscription", so the month is consistent here. ⛔ A NASAL SPRAY, not an injection
NAD+: $350 — ⛔⛔ THE SELLER'S OWN ARITHMETIC CONTRADICTS ITS OWN LABEL. The page prints "$350 — $5.83 per day" for both the subscription and the one-time option, and the shop label reads "$350 - Monthly Subscription". But $350 ÷ $5.83 = 60.0 days, not 30 — while the same seller's growth-hormone page divides by exactly 30. Recorded as not a monthly rate because the page's own division says sixty days. ⛔ A NASAL SPRAY, not an injection
LaSara Medical Group is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Doing the division changes what one number means
Both peptide product pages offer a one-time purchase and a subscription, and print a per-day figure beside each. That is a small generosity: most sellers on this roster publish a figure and nothing to check it against.
On the growth-hormone product the divisions are consistent. Both the one-time figure and the subscription figure divide by exactly thirty days, and the shop label calls it a monthly subscription. Everything agrees.
On the coenzyme product the same figure appears for both options, and its per-day division resolves to sixty days rather than thirty. The shop label still calls it a monthly subscription.
One of those two products is being described by its own arithmetic as a two-month supply and by its own label as a monthly one. This site records the growth-hormone figure as a monthly rate and the coenzyme figure as one that is not, and puts the division in the qualifier so a reader can check it.
Both peptides are nasal sprays
The paths this session requested for both products redirected, and the pages served name the route in the URL and in the product title: both compounds are sold as nasal sprays.
That is a genuine route distinction and this roster records it. A reader comparing injectable figures for the same compounds across other sellers should not find these among them without the route attached.
The seller is clear about it. Nothing here requires inference, and the redirect actually improves the citation by landing on a URL that states the route.
The roster cites the effective URLs on both rows.
The terms name a website vendor and nobody else
A census of the terms page found exactly one corporate name on it, in a copyright line, and it belongs to the platform that builds websites for medical practices.
No limited liability company, incorporated company, professional corporation or professional limited liability company is attached to this brand's name anywhere on the page.
That is the third seller in this batch whose only published corporate name belongs to a vendor rather than an operator — one a website platform, one a payment processor, one a telehealth software company.
The seller does publish a street address with a mailbox number and a phone number in its footer, which is more contact detail than several rows here carry.
Cross-page consistency is not a habit here
The seller's weight-loss lane has the same problem in a different place: its about page prints a starting monthly figure for a compound whose product page prints a one-time purchase price with a per-day division, and the two do not match.
That is not a peptide fact and it does not appear on the roster rows. It appears here because it establishes that the coenzyme discrepancy is a pattern rather than a typo.
The catalogue also names a copper peptide in its product rail, described in the seller's own promotional copy. No figure for it was reached on the pages read.
No dispensing pharmacy is named, no certificate of analysis exists on the pages read, and no state coverage list is published. Screened by brand and by the vendor name against the regulator's warning-letter index, nothing returns.
Who it's for
Readers who check arithmetic, because on this seller checking it changes what one of the two figures means.
Buyers who want a per-day figure printed beside a price.
Anyone shopping specifically for a nasal spray rather than an injection.
Shoppers who want a street address and a phone number published.
Who should look elsewhere
Anyone who needs the coenzyme's billing period settled, which its own page and its own label disagree about.
Readers who want an operating company published under the brand's name rather than a website vendor's.
Buyers who want an injectable form of either compound.
Shoppers who want a certificate of analysis, a named pharmacy, or a state coverage list.
Strengths
Prints a per-day division beside every figure, which is what made the sixty-day discrepancy visible at all
Names the route in the product URL and the product title, so a nasal spray is never mistaken for an injection
Publishes the subscription tier and the one-time price side by side with the discount stated as a percentage
Publishes a street address and a phone number in the footer of every page
Trade-offs
The coenzyme's own per-day figure implies a sixty-day supply while its shop label calls it a monthly subscription
The only corporate name on its terms belongs to its website platform vendor
Its weight-loss pages carry a figure that does not match the one on its about page, so cross-page consistency is not a habit here
No pharmacy named, no certificate of analysis, no state coverage list
How we verified this
Loaded both product paths and the terms with a full browser user-agent, printing the effective URL beside the requested one on each and recording that both product paths redirected.
Cited the effective URLs, which name the route in the slug, on both price rows.
Ran a nonsense-path control on the host in the same run, which returned a not-found status.
Joined the page's text nodes before matching any figure, so a price split across elements could not read as an absence.
Divided each published figure by its own published per-day figure and recorded the resulting day count on both products, which is what surfaced the sixty-day division.
Recorded the growth-hormone figure as a monthly rate and the coenzyme figure as one that is not, on the strength of the seller's own arithmetic rather than its label.
Ran a census of the terms page for corporate-suffix tokens attached to the brand name and found none, with the only corporate name on the page belonging to a website platform vendor.
Screened the brand and the vendor name against the regulator's warning-letter index, with a nonsense query as a control in the same run.
A provider to compare LaSara Medical Group against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Its shop label says so and its own per-day division resolves to sixty days rather than thirty. This site records it as a figure that is not a monthly rate for that reason.
Are these injections?
No. Both peptide products are nasal sprays, and the seller says so in the product title and the URL.
Who operates this practice?
No entity carrying the brand's name appears on its terms. The only corporate name on that page belongs to its website platform vendor.
Is the one-time price different from the subscription?
On the growth-hormone product, yes, and the subscription is discounted by a stated percentage. On the coenzyme both options show the same figure.
Does it sell a copper peptide?
It names one in its product rail with its own promotional description. No figure for it was reached on the pages read.
LaSara Medical Group is not a paid partner; this link may earn a commission if that changes. Full disclosure.